Pharmaceutical formulations of a substituted diaminopurine

US8603527B2 · kind B2 · utility

Assignee

• Signal Pharmaceuticals, LLC · US

Inventors

• Sreenivas S. Bhat · Kendall Park, US
• Xiaozhong Liang · Edison, US
• Anthony Tutino · New Providence, US
• Anthony Joseph Frank · Easton, US

Key dates

• Filing date: Oct 20, 2011
• Grant date: Dec 10, 2013
• Expiry date: Nov 26, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are pharmaceutical formulations, comprising 4-((9-((3S)-tetrahydro-3-furanyl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)-trans-cyclohexanol, including pharmaceutically acceptable salts, solvates, isomers, isotopologues, tautomers and racemic mixtures thereof, and a pharmaceutically acceptable excipient; and their use for treating or preventing disease.